ZIM Laboratories Limited (NSE:ZIMLAB)
India · Delayed Price · Currency is INR 135.41
-1.45 (-1.06%)
Nov 11, 2026, 2:19 PM IST
ZIM Laboratories Market Cap
ZIM Laboratories has a market cap or net worth of 7.3 billion as of November 10, 2026. Its market cap has increased by 112.63% in one year.
Market Cap
7.30B
Enterprise Value
8.59B
Revenue
4.13B
Global Rank
n/a
Country Rank
n/a
PE Ratio
337.28
ChartMarket Cap Chart
Since June 11, 2018, ZIM Laboratories's market cap has increased from 1.68B to 7.30B, an increase of 334.23%. That is a compound annual growth rate of 19.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 7.30B | 108.43% |
| Dec 31, 2025 | 3.50B | -33.11% |
| Dec 31, 2024 | 5.24B | -6.72% |
| Dec 29, 2023 | 5.62B | 18.57% |
| Dec 30, 2022 | 4.74B | 146.60% |
| Dec 31, 2021 | 1.92B | 31.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 21.69B |
| Windlas Biotech | 20.59B |
| Indoco Remedies | 19.85B |
| Beta Drugs | 18.31B |
| Anlon Healthcare | 14.35B |
| Jagsonpal Pharmaceuticals | 14.06B |
| Bafna Pharmaceuticals | 10.75B |
| Sigachi Industries | 10.53B |